ABSTRACT To define the role of oxygen free radicals and neutrophil involvement in evolving myocardial reperfusion injury, we evaluated the effect of 2-octadecylascorbic acid (CV-3611). a novel free radical scavenger, on neutrophil function and the extent of myocardial damage resulting from 90 min of ischaemia followed by 5 h of reperfusion in an experimental model of myocardial infarction. Dogs were randomly assigded to receive CV-3611 (5 mg.kg-l.[5 minl-l, intravenously) just before the onset of reperfusion. Infarct size, as a percent of area at risk, was reduced by 60% in CV-3611 treated group as compared with control, at 16.7(SEM 3. I)% v 41.5(4.5)%, p<O.Ol. Administration of CV-36 1 1 markedly reduced function of neutrophils isolated from peripheral circulation during reperfusion ex vivo as estimated by free radical generation (ferricytochrome c reduction and luminol enhanced chemiluminescence), chemotactic activity, and aggregation induced by A23187. Under these conditions, the enhancement in neutrophil infiltration and free radical generation (luminol enhanced chemiluminescence) in myocardium within area at risk, especially in the border zone between viable and irreversible injured myocardium, was markedly reduced. Haemodynamic profiles were similar between control and CV-3611 treated group. These results suggest that activated neutrophils, especially their generation of oxygen free radicals, contribute to reperfusion induced myocardial injury.
It has been demonstrated that neutrophils appear in the ischaemic myocardium and agents causing neutrophil depletion or anti-inflammatory action produce limitation of infarct size, associated with attenuation of neutrophil infiltration, in a canine coronary occlusion-reperfusion model of myocardial infarction,14 suggesting an important role of neutrophils in evolving reperfusion injury. The mechanism by which neutrophils mediate tissue injury has been shown to be related to their ability to release several active substances including oxygen free radicals. In fact, increasing evidence indicates that oxygen free radicals may contribute to myocardial injury during ischaemia followed by reperfusion.'-' However, the pathophysiological mechanisms of reperfusion injury induced by these radicals are not well understood. Since these radicals could be generated at both intracellular and extracellular spaces during reperfusion,'-' I free radical scavengers having amphipathic property in the molecule would be ideal for protection of the injured myocardium.
In the present study we examined the effects of a novel free radical scavenger, 2-octadecylascorbic acid (CV-361 on the extent of irreversible injury, neutrophil function and free radical generation in injured myocardium, estimated by chemiluminescence assay, in a canine occlusion-reperfusion model of myocardial infarction. We demonstrate that CV-3611 is an effective free radical scavenger that provides significant reduction in reperfusion induced myocardial injury, associated with suppression of neutrophil activity.
Methods

EXPERIMENTAL PROTOCOL
Twenty two adult mongrel dogs (10-14 kg) were anaesthetised with sodium pentobarbitone (30 mg.kg-' intravenously), intubated with a cuffed endotracheal tube, and artificially ventilated with room air. Each dog had continuous electrocardiographic and haemodynamic monitoring throughout the course of the experiment. The left jugular vein was cannulated for blood sampling and drug administration. A left thoracotomy was performed at the fifth intercostal space and the heart was suspended in a pericardial cradle. The left anterior descending coronary artery (LAD) was dissected free at the level of the first major diagonal branch and a silk ligature passed around it. Total occlusion was maintained for 90 min followed by 5 h of reperfusion. At the end of reperfusion, a short cannula was inserted in the LAD at the site of occlusion and the retrograde flow from the LAD was measured for 1 min.
Just before reperfusion 11 dogs (treatment group) received CV-3611 (5 mg*kg-'.[5 mini-I, iv), which was dissolved in 20 mi 0.9% sodium chloride. Control group received an equal volume of vehicle solution.
QUANTIFICATION OF AREA AT RISK AND INFARCT SIZE
After the measurement of retrograde flow from the LAD, the extent of the area at risk and myocardial infarction was determined as we have described previously.13 In brief, Evans blue dye was injected into the jugular vein, while the cannulated LAD was perfused with autologous heparinised blood. The heart was rapidly excised and sliced in three transverse sections. Each of these sections was subdivided into two sections: the apical half was used for measurements of free radical generation and histological examination and the basal half for the evaluation of area at risk and infarcted area. The area at risk was identified by the lack of Evans blue stain. After the incubation in triphenyltetrazolium chloride solution, the infarcted area remained colourless due to the loss of dehydrogenase enzymes from the irreversibly injured tissue. The extent of myocardial injury was also determined by the plasma creatine kinase (CK) level.
Plasma was separated from the heparinised blood withdrawn for the isolation of neutrophils. There was no significant effect of CV-3611 on the CK assay.
HISTOLOGICAL EXAMINATION
Samples of myocardium were taken from the central infarcted region, the non-infarcted tissue within area at risk, and the endocardial to epicardial border zone between infarcted region and area at risk. The tissue blocks were embedded in paraffin, cut to a thickness of 6 p n , and stained with haematoxylin and eosin. Light microscopy was used to assess the extent of neutrophil infiltration into the ischaemic myocardium. Neutrophil infiltration was assessed by counting the number of neutrophils in 10 randomly selected fields of each stained section at magnification of ~400. Repetitive blind trials of the same tissue samples confirmed that the results were reproducible and all sections were examined by a pathologist who was unaware of the experimental protocol.
FREE RADICAL GENERATION IN MYOCARDIAL TISSUE
Samples of myocardium were taken from three different regions as described above, ie, central infarcted region, border zone, and non-infarcted area at risk. Myocardial samples were also taken from normal control dogs. These samples were finely chopped on ice in minimum essential medium (MEM, pH 7.4). It is important to note that the myocardial sampling procedure must be performed as quickly as possible, in the same way as cell culture. We measured free radical generation of the chopped tissue samples in 3 ml of MEM by chemiluminescence assay with a liquid scintillation counter (Tracor Analytic, Mark 111) using a modified method described previously. l4 After 1 min preincubation with luminol(2 mg.litre-' in final concentration), the reaction was initiated by adding calcium ionophore A23187 (2 pmol.litre-' in final concentration). Luminol was dissolved in dimethyl sulphoxide, 10 g-litre-'. This stock solution was diluted 1/100 with redistilled water before use. We dissolved A23187 in dimethyl sulphoxide at a concentration of 50 mmol*litre-' and stored it at -20°C. The stock solution was diluted in Dulbecco's phosphate buffered saline (PBS) before use. Background counts per min (cpm) generally ranged from 8 to 10 x lo3. For statistical treatment of chemiluminescence measurements, the chemiluminescence emission was assessed by the maximal value of each sample within 5 min of the addition of A23 187.
MEASUREMENTS OF NEUTROPHIL FUNCTION
Peripheral blood was drawn into a heparinised syringe before thoracotomy , after LAD occlusion, and every hour after reperfusion. Leucocyte count was determined by a model CC-130A microcell counter (Sysmex, Japan). Neutrophils were isolated by the Percoll gradient method15 with a minor modification. l 3 In brief, after removing platelet rich plasma, the buffy coat was layered on 55% isotonic Percoll solution and centrifuged at I600 g for 20 min. The neutrophil rich layer on the erythrocyte pellet was collected and contaminated erythrocytes were lysed with 0.15 mol.litre-l ammonium chloride.
Free radical generation -Free radical generation in isolated neutrophils was examined by two different methods.
(1) Chemiluminescence assay as described above was used.14 A 2 ml aliquot of the neutrophil suspension (2 X lo6 cells in Dulbecco's PBS) stimulated with A23187 (2 pmol.litre-' in final concentration) was preincubated at 37°C in a plastic liquid scintillation minivial (6 ml). For statistical treatment of chemiluminescence measurements, the chemiluminescence emission was assessed 5 min after addition of luminol (0.2 mgslitre-l in final concentration) to the sample after a 15 min preincubation period. In our preliminary study, this luminol enhanced chemiluminescence of neutrophil samples reached a maximum after 15 min preincubation and thereafter declined (data not shown). Serial changes in chemiluminescence (cpm) were examined by comparing with that before thoracotomy (100%). Cells without luminol do not produce chemiluminescence, nor does luminol without cells and/or A23187. Though dimethyl sulphoxide has been reported to be a hydroxyl radical scavenger,I6 the chemiluminescence assay in neutrophils was not affected by this agent at 10 mI.1itre-l.
(2) The generation of superoxide anion was measured by a modification of the method of Babior et al." Superoxide anion was assayed by measuring superoxide anion dependent (superoxide dismutase inhibitable) reduction of ferricytochrome c, which was recorded graphically as the increase in absorbance at 550 nm (nanomolar extinction coefficient: 0.021). Neutrophils were suspended in Dulbecco's PBS ( 1 X lo9 cells-litre-l) containing femcytochrome c (0.1 mmol.litre-I) in the presence or absence of superoxide dismutase (SOD, 20 pg). After 1 min equilibration at 37"C, the cuvettes were stimulated with A23187 (20 pmol.litre-' in final concentration). Serial changes in superoxide anion generation were expressed as the percent change in the maximal level of femcytochrome c reduction compared with that before thoracotomy , Chemotaris assay -Chemotactic activity of neutrophils was assayed with a 48 well micro chemotaxis chamber (Neuro Probe, Inc) as described 325 by Falk et all8 with a minor modification." In brief, neutrophils ( lo' cells.litre-' Dulbecco's PBS) placed in the top wells of the chamber migrated through a filter sheet (3 p M PVPF, Neuro Probe, Inc) to the bottom well filled with chemotactic leukotriene B4 (LTB4, 100 nmol.litre-I) during incubation at 37°C for 1 h. The migrated cells that had reached the bottom surface of the sheet were counted microscopically after the filter was fixed and stained. Serial changes in chemotactic activity were examined as the percent change in the number of migrated neutrophils at the specified time of reperfusion compared with that before thoracotomy . A chemotactic index was defined as the number of migrated neutrophils induced by LTB4 divided by the number of neutrophils migrated without chemo-attractant.
Aggregation -Neutrophil aggregation was monitored in a model RAM multichannel aggregometer (Rikadenki) with stimng at 1100 rpm and was performed with 0 and 100% light transmission preset with the neutrophil suspension ( 10'' cells.litre-l in Dulbecco's PBS) and its diluted suspension (5 X lo9 cells*litre-l), respectively.20 Neutrophil aggregation was induced by A23 187 (10 pmol-litre-' in final concentration). Serial changes in neutrophil aggregation were examined as the percent change by comparing with that before thoracotomy .
EVALUATION OF EFFECTS OF CV-3611 ON FREE RADICAL GENERATION IN NEUTROPHILS IN VITRO
Canine neutrophils were isolated from venous blood of untreated dogs and separated by Percoll gradient centrifugation. Effect of CV-3611 on A23 187 induced free radical generation in neutrophils was evaluated by chemiluminescence assay and SOD inhibitable reduction of femcytochrome c as described above. CV-3611, diluted in dimethyl sulphoxide, was added to the incubation tubes 1 min before the addition of A23 187. The effect of CV-3611 was expressed as the percent changes in the chemiluminescence emission (chemiluminescence assay) or in the absorbance at 550 nm (femcytochrome c reduction) compared with those in the controls.
CV-3611 was not directly toxic to neutrophils because cell viability, as determined by trypan blue dye, was not affected even at 100 pmol.litre-'.
CHEMICALS
CV-3611 was the gift from Takeda Chemical Industries, Ltd. Percoll was purchased from Pharmacia, SOD (3050 U*mg-l protein) from Sigma, and A23 187 from Calbiochem. Other chemicals were purchased from Wako Pure Chemical Industry.
STATISTICAL ANALYSIS
Unpaired and paired t tests were used in the statistical analysis of the data. Data are expressed as mean(SEM).
Results
EFFECT OF CV-3611 ON ISCHAEMIC MYOCARDIAL TISSUE
Administration of CV-3611 just before reperfusion significantly reduced the infarct size (fig I) . Percent of the risk area infarcted, assessed by the double staining method, was41.5(4.5)% incontroland 16.7(3.1)% in CV-3611 treated group. In control dogs, plasma CK levels increased gradually after 90 min of occlusion and reached 6100(979) IU.litre-' at 5 h of reperfusion. The increase in CK level was markedly attenuated in the treated group, at 2605(370) IU-litre-' after 5 h of reperfusion, p<0.05 v control.
Neutrophil infiltration into the ischaernic myocardium was assessed by counting the number of infiltrated neutrophils with light microscopy (fig 2,  upper panel) . In control hearts the neutrophil count in tissue samples taken from the endocardial to epicardial border zone and the central infarcted region was markedly augmented compared with that in the non-infarcted area at risk or in normal tissue. The neutrophil accumulation both in the border and infarcted regions was markedly suppressed by the treatment of CV-3611.
When A23 187 induced free radical generation from the myocardial tissue samples was assayed by luminol enhanced chemiluminescence, the chemiluminescence (cpm-g-' tissue) was significantly increased in the region of peri-infarcted area. In particular the chemiluminescence in the border zone was more than three times greater than that in the other three regions (fig 2, lower panel) . The mean value in the central infarcted region was almost equal to that from the normal myocardial tissue. The regional change in the chemiluminescence was also seen at the study in the absence of A23187 (data not shown). Administration of CV-3611 resulted in a significant reduction in the chemiluminescence in the non-infarcted tissue within the area at risk and the border zone.
FIG 2 Effecr of CV-361 I on neurrophil accumularion and luminol enhanced chemiluminescence emission wirhin the heart after ischaemia followed by reperfusion (see Methods for experimental detail). Tissue samples were obtained from the non-infarcred tissue wiihin rhe area ar risk (harched region, risk), from the endocardial to epicardial border zone between infarcted and non-infarcted tissue (border), from the central infarcted region (black region, infarct), and from the normal control dog (normal
EFFECT OF CV-3611 ON NEUTROPHIL FUNCTION
The leucocyte count in peripheral blood increased gradually during reperfusion in the control group, from 8.0(1.1) x lo9 litre-' before thoracotomy to 14.1(1.0) X lo9 litre-' after 5 h of reperfusion, whereas treatment with CV-3611 significantly suppressed the increase in leucocyte count even after 5 h of reperfusion, when it was only 8.6(0.9) X lo9 litre-' (pCO.05 v control). Free radical generation in peripheral neutrophils ex vivo, assessed by luminol enhanced chemiluminescence and ferricytochrome c reduction, significantly increased after reperfusion in the control group (table). There were no differences in chemiluminescence emission and superoxide anion generation in A23 187 stimulated neutrophils isolated before thoracotomy between control and CV-36 1 A chemotactic index of neutrophils isolated before thoracotomy was 1.84(0.28) and 1.85(0.31) incontrol and CV-3611 treated groups, respectively. The chemotactic activity of neutrophils increased significantly after reperfusion and reached its maximal value at 4 h of reperfusion in the control group (8 1 % elevation compared with that before thoracotomy) .
Though the mean value for chemotactic activity in the 327 treated group was markedly less than in the controls, it failed to reach statistical significance.
Serial change in neutrophil function during reperfusion was also manifested by neutrophil aggregation. A23 187 induced aggregation of neutrophils isolated before thoracotomy was 52(6)% and 54(7)% in control and CV-3611 treated groups, respectively. In the control group, neutrophil aggregation increased gradually after reperfusion and a 46% increase was seen at 4 h of reperfusion compared with that before thoracotomy . Treatment with CV-3611 markedly reduced the neutrophil aggregation and 20% reduction was seen at I h of reperfusion. Even at 4 h of reperfusion, there was no significant elevation in the neutrophil aggregation compared with that before thoracotomy.
COLLATERAL BLOOD FLOW AND HAEMODYNAMICS
According to the degree of retrograde flow from the LAD, we divided all dogs into three groups as previously reportedi9: (a) <0.5 rnl.min-', (b) 30. 5 and <3 ml.min-', and (c) 3 Baseline heart rate and arterial pressure were similar in control and CV-3611 treated groups. The haemodynamic effect of CV-3611 was assessed by the rate pressure product (systolic blood pressure X heart rate). There were no significant differences between control and the treated group.
INHIBITION OF FREE RADICAL GENERATION OF ISOLATED NEUTROPHILS IN VITRO BY CV-361 I
CV-3611 exhibited a concentration dependent inhibition of free radical generation, assessed by The in vitro studies demonstrate the ability of 
Discussion
The present study demonstrated that CV-3611, a potent free radical scavenger, effectively reduced myocardial injury in a canine occlusion-reperfusion model of myocardial infarction when administered immediately before the onset of reperfusion. CV-3611 also suppressed the hyperreaction of neutrophils during reperfusion as estimated by free radical generation, chemotactic activity, and aggregation. Interestingly, the reduction in ultimate infarct size by CV-3611 was associated with decreases in neutrophil infiltration and free radical generation in myocardium within the risk region, especially in the border zone. The findings that CV-3611 had no effect on the retrograde flow from the LAD and other haemodynamic variables indicate that this drug exerts its cardioprotective actions without altering myocardial oxygen consumption. Myocardial infarction is associated with an acute inflammatory response, which leads to neutrophil infiltration into ischaemically injured tissue." Recent studies indicated that ischaemic myocardial injury can contribute to limitation of infarct size in ischaemic-, reperfused myocardium, since administration of CV-3611 markedly suppressed the hyperfunction of neutrophils after reperfusion, including the increased production of oxygen free radicals (table) . These findings coincide with the other reportz7 that N-2 mercaptopropionyl glycine, with its inhibitory effect on free radical generation from neutrophils, can limit infarct size.
Though the source of free radicals generated in myocardium remains to be seen, differences in luminol enhanced chemiluminescence emission in A23 187 stimulated myocardial tissue taken from four different regions attract special interest. The endocardia1 to epicardial border zone between infarcted region and area at risk showed the most prominent chemiluminescence among four regions, indicating an important role of free radicals on evolving myocardial infarction in this area. On the other hand the chemiluminescence emission in the central infarcted region was as low as that in the normal area. These observations indicate that the occurrence of irreversible injury in the central infarcted region may not itself be able to cause an increased generation of free radicals. Administration of CV-3611 significantly reduced the chemiluminescence emission in tissues taken from the border zone and the non-infarcted region within the area at risk. Moreover, an increase in neutrophil infiltration in myocardial tissue, especially taken from the border zone and the central infarcted region was effectively reduced by CV-3611 treatment. It is, therefore, feasible that the effect of CV-3611 in reducing infarct size is closely linked to the effects on free radical generation and neutrophil infiltration in the area at risk. Interestingly, there was a dissociation between the extent of neutrophil infiltration and free radical generation in the central infarcted zone, whereas both indices were increased in the border zone. These findings indicate the possibility that infiltrated neutrophils exhibit more pronounced chemiluminescence emission when they are in the reversible ischaemic myocardium. On the other hand, CV-3611 may also have reduced reperfused myocardial injury through another mechanism, indirectly leading to attenuation of neutrophil activation and infiltration. However, in view of potent effects of neutrophil derived substances on tissue injury, persistence of the inhibitory effect of CV-3611 on neutrophil function may be important in reducing the infarct size. Further work is needed to define the source of free radicals generated in the area at risk and the significance of these active substances on evolving myocardial cell injury.
It should be noted that only a 5 min infusion of CV-3611 just before reperfusion effectively salvaged reperfused myocardial injury. In other reports attempting to describe myocardial salvaging effect of radical scavengers, the drugs were administered for about 60 min around the time of reperfusion.*' *' Furthermore, the inhibitory effect of CV-3611 on neutrophil function ex vivo was persistent for at least 4 h after reperfusion in this study, possibly due to the "anchoring" effect of CV-3611 with a long chain fatty acid moiety on the plasma membrane. In the clinical setting, such a characteristic of this drug would be favourable in preventing myocardial injury induced by oxygen free radicals when patients with acute myocardial infarction are subjected to reperfusion therapy.
